Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Abbott Laboratories (ABT)

Abbott Laboratories (ABT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 212,365,520
  • Shares Outstanding, K 1,776,820
  • Annual Sales, $ 34,608 M
  • Annual Income, $ 4,495 M
  • 60-Month Beta 0.68
  • Price/Sales 6.20
  • Price/Cash Flow 21.67
  • Price/Book 6.22
Trade ABT with:

Options Overview

Details
  • Implied Volatility 19.38%
  • Historical Volatility 16.38%
  • IV Percentile 8%
  • IV Rank 8.10%
  • IV High 42.81% on 08/27/20
  • IV Low 17.31% on 06/10/21
  • Put/Call Vol Ratio 1.97
  • Today's Volume 13,182
  • Volume Avg (30-Day) 13,735
  • Put/Call OI Ratio 1.14
  • Today's Open Interest 185,714
  • Open Int (30-Day) 187,553

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate 0.92
  • Number of Estimates 8
  • High Estimate 0.93
  • Low Estimate 0.90
  • Prior Year 0.98
  • Growth Rate Est. (year over year) -6.12%

Price Performance

See More
Period Period Low Period High Performance
1-Month
112.74 +6.01%
on 06/28/21
121.10 -1.30%
on 07/23/21
+6.80 (+6.03%)
since 06/25/21
3-Month
105.36 +13.44%
on 06/02/21
122.55 -2.47%
on 04/27/21
-3.06 (-2.50%)
since 04/26/21
52-Week
98.41 +21.45%
on 07/27/20
128.54 -7.02%
on 02/12/21
+20.57 (+20.79%)
since 07/24/20

Most Recent Stories

More News
Antiepileptic Drugs Market 2021 Industry Trends, Complete Data Analysis across the Region and Globe, Opportunities and Growth Forecast 2030

In a recent published report, Kenneth Research has updated the market report for Antiepileptic Drugs Market for 2021 till 2030. Report further now discusses; the various strategies to be adopted or being...

ABT : 119.52 (-1.06%)
GSK : 39.02 (-1.24%)
NVS : 90.96 (-0.67%)
PFE : 41.81 (+0.31%)
VRX.TO : 30.80 (-3.33%)
Insights on the Pain Management Drugs Gulf Market to 2027 - Opportunity Analysis and Industry Forecasts

/PRNewswire/ -- The report has been added to offering.

ABT : 119.52 (-1.06%)
LLY : 243.21 (-0.39%)
MRK : 77.24 (-0.39%)
NVS : 90.96 (-0.67%)
PFE : 41.81 (+0.31%)
Building Trust and Improving Care in Underserved Communities

--News Direct--

ABT : 119.52 (-1.06%)
Acyclovir Herpes Labialis Treatment market is expected to continue its dominance throughout the forecast period 2027

Attributed to rising penetration of generics and innovations in disease treatment, the US$ 869.3 Mn global is anticipated to expand at a CAGR of 4.6% over 2017-2027, attaining a value worth US$ 1,358.7...

ABT : 119.52 (-1.06%)
NVS : 90.96 (-0.67%)
PFE : 41.81 (+0.31%)
TEVA : 8.94 (+1.48%)
VRX.TO : 30.80 (-3.33%)
Worldwide Extracorporeal Membrane Oxygenation Machine Industry to 2025 - Featuring Abbott Laboratories, Braile Biomedical & Eurosets Among Others

The "Global Extracorporeal Membrane Oxygenation Machine Market (2020-2025) by Components, Modality, Application, Patient Type, End-User, Geography, Competitive Analysis and the Impact of Covid-19 with...

ABT : 119.52 (-1.06%)
Third Day of Gains Despite Rising Jobless Claims

Third Day of Gains Despite Rising Jobless Claims

MSFT : 289.05 (-0.21%)
AMZN : 3,699.82 (+1.18%)
FB : 372.46 (+0.72%)
AAPL : 148.99 (+0.29%)
NFLX : 516.49 (+0.21%)
INTC : 54.31 (+2.47%)
ABT : 119.52 (-1.06%)
DHR : 290.18 (-0.37%)
T : 28.18 (+0.11%)
UNP : 220.19 (+0.02%)
SNAP : 76.32 (-2.12%)
TWTR : 68.69 (-4.18%)
HON : 229.25 (-0.03%)
AXP : 172.61 (-0.33%)
TSLA : 657.62 (+2.21%)
Global Acute Otitis Media Treatment Market by Emerging Trends, Future Growth, Revenue Analysis, Demand Forecast, Top Key Players Forecast To 2030

In a recent published report, Kenneth Research has updated the report for for 2021 till 2030. Report further now discusses; the various strategies to be adopted or being adopted by the business players...

ABT : 119.52 (-1.06%)
BAYRY : 15.1210 (+1.01%)
LLY : 243.21 (-0.39%)
GSK : 39.02 (-1.24%)
NVS : 90.96 (-0.67%)
PDP.VN : 0.300 (+1.69%)
Covid-19 Tests Innovations Drawing New Interest from FDA and Consortiums

/PRNewswire/ --   -  Two of the world's most prominent billionaires, and , recently made headlines backing a consortium to buy UK Covid-19 test maker  for  ahead of a new initiative of a global rollout...

BVAXF : 0.1910 (+4.71%)
BIOV.CN : 0.240 (unch)
ABT : 119.52 (-1.06%)
CEMI : 2.97 (-2.94%)
QDEL : 139.73 (-6.98%)
OCDX : 21.33 (+0.33%)
Covid-19 Test Innovations Drawing New Interest from FDA and Consortiums

VANCOUVER – USA News Group – Two of the world’s most prominent billionaires, George ...

LMNGF : 0.2405 (-7.00%)
ABT : 119.52 (-1.06%)
CEMI : 2.97 (-2.94%)
QDEL : 139.73 (-6.98%)
OCDX : 21.33 (+0.33%)
BIOV.CN : 0.240 (unch)
Abbott (ABT) Q2 Earnings Beat, Molecular Diagnostic Sales Drop

Abbott's (ABT) Adult Nutrition sales benefit from improved sales performance of complete and balanced nutrition brand Ensure and diabetes nutrition brand, Glucerna in Q2.

ABT : 119.52 (-1.06%)
ALGN : 635.58 (-0.42%)
AMN : 98.47 (+0.03%)
CTLT : 113.00 (-2.80%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. They have a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals.

See More

Key Turning Points

3rd Resistance Point 122.65
2nd Resistance Point 121.57
1st Resistance Point 120.54
Last Price 119.52
1st Support Level 118.44
2nd Support Level 117.36
3rd Support Level 116.33

See More

52-Week High 128.54
Last Price 119.52
Fibonacci 61.8% 117.03
Fibonacci 50% 113.48
Fibonacci 38.2% 109.92
52-Week Low 98.41

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar